Research
Topics:
INDEX
AI-chat 5
PRIME 23
aging 4
brain 12
cancer 3
censorship 1
climate 1
cognition 2
crime 4
culture 4
economy 5
gender 1
genetics 4
gut 1
heart 1
herbs 1
immune 1
lungs 2
microbiome 1
misc
nutrition 1
pain 1
politics 8
psychology 7
reproduction 2
sleep 2
soc-media
unk
vaccine 1
war-confl
 
Scanned: 2635
Evaluated: 135
Selected: 48

 
    HEART   

Mcr02-028

Differential Outcomes with Empagliflozin and Dapagliflozin in Heart Failure with Mildly Reduced Ejection Fraction

Quote:Conclusions In this large real-world HFmrEF population, empagliflozin was associated with lower mortality, hospitalization, and HF exacerbation compared with dapagliflozin, with no significant difference in UTI risk. These findings suggest potential heterogeneity in clinical effectiveness among SGLT2 inhibitors in HFmrEF and warrant confirmation in prospective comparative studies.
Abstract: https://www.medrxiv.org/content/10.64898/2026.01.09.26343819v1
Full Text: https://www.medrxiv.org/content/10.64898/2026.01.09.26343819v1.full-text
Search Similar: Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho 
Search Authors: Ibrahim Mortada Aaron Lee Ayushi Sahu Erin Vidal Krishna Paul Yazeed Alhanbali Shareef Mansour Khaled Chatila Dietrich Jehle Thomas Blackwell Hani Jneid, 

  Updated weekly. 01/16/2026-10:53:04 PM
Javilk's Research Links
Drop me a note to subscribe.
What interests you?